Bayer HealthCare Pharmaceuticals (BAY) Receives FDA Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler
Tweet Send to a Friend
Bayer HealthCare Pharmaceuticals (NYSE: BAY) announced that an orphan drug designation has been granted by the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
